Free Webex Call
The Global Coronavirus Vaccine Market is expected to grow at a robust rate in value terms to reach USD 91325.46 million by the end of 2021. Coronaviruses are a group of viruses belonging to the coronaviridae family that can affect both mammals and birds. The common symptoms include mild illness such as common cold, respiratory tract infections, among others. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The ongoing pandemic novel coronavirus disease (COVID-19) is caused due to SARS-COV-2 and generally spreads from animals to humans and then from humans to humans. The disease usually spreads from the saliva droplets of the infected person or the nose discharges of the infected person when they cough or sneeze. The first case of the disease was reported in December 2019 in Wuhan, China and since then, it has spread to various parts of the world infecting millions. As of 23rd May 2021, coronavirus has affected more than 200 countries with the total number of coronavirus cases reaching 168,032,098 out of which 149,371,973 have recovered and around 3,488,577 people have succumbed to the disease.
The Global Coronavirus Vaccine Market is expected to grow at a robust rate during the forecast period. The Global Coronavirus Vaccine Market is driven by the increasing prevalence of this disease across different parts of the globe. This has increased the need to protect the world from the virus, thereby increased sales of coronavirus vaccine through 2026. Furthermore, increasing research and development activities by various pharmaceutical & biotechnology players for the development of potential vaccines is anticipated to foster the market growth. According to WHO, there are more than 70 coronavirus vaccines under development by different companies and organizations.
Currently, mRNA-based vaccine named Moderna COVID-19 Vaccine (mRNA-1273), adenovirus-based vaccine named COVID-19 Vaccine AstraZeneca (AZD1222) also known as Covishield in India and Sputnik V which constitutes recombinant adenovirus vaccine which is developed by Gamaleya Research Institute, Russia are being used for vaccination among adults. The vaccine developed by Moderna, Inc., Pfizer Inc., AstraZeneca PLC are leading the race and is currently administered to entire population. T-COVIDTM, AdCOVID and COVI-VAC are intranasal COVID-19 vaccines which are under pre-clinical and phase 1 trials.
The Global Coronavirus Vaccine Market is segmented based on infection type, vaccine type, product type, route of administration, patient type, end-user, company, and region. Based on infection type, the market can be categorized into SARS-CoV-2, SARS-CoV and MERS-CoV. The SARS-CoV-2 segment is expected to dominate the market since this infection or virus is the primary cause of the pandemic.
Regionally, the Global Coronavirus Vaccine Market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, Asia-Pacific is expected to witness significant growth during the forecast period in the overall coronavirus vaccine market.
Major players operating in the Global Coronavirus Vaccine Market include Moderna, Inc., Johnson & Johnson SA, Pfizer Inc., Sinopharm Group Company Ltd., AstraZeneca PLC, are the leading companies and Serum Institute of India Pvt Ltd., Bharat Biotech International Ltd., Sinovac Biotech Ltd., Sanofi SA, GlaxoSmithKline PLC, Novavax, Inc., Airway Therapeutics, Inc., Cadila Healthcare Ltd., CanSino Biologics Inc., Mitsubishi Chemical Holdings Corporation, Eubiologics Co. Ltd., United Biomedical Inc., Merck & Co., Inc., CureVac N.V., Inovio Pharmaceuticals, Inc. among others. The companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.
Years considered for this report:
- Base Year: 2020
- Estimated Year: 2021
- Forecast Period: 2022-2026
Objective of the Study:
- To analyze and estimate the market size of the Global Coronavirus Vaccine Market from 2021 to 2026.
- To estimate and forecast the market size of the Global Coronavirus Vaccine Market from 2022 to 2026 and growth rate until 2026.
- To classify and forecast the Global Coronavirus Vaccine Market based on infection type, vaccine type, product type, route of administration, patient type, end-user, company, and regional distribution.
- To identify dominant region or segment in the Global Coronavirus Vaccine Market.
- To identify drivers and challenges for the Global Coronavirus Vaccine Market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Coronavirus Vaccine Market.
- To conduct pricing analysis for the Global Coronavirus Vaccine Market.
- To identify and analyze the profile of leading players operating in the Global Coronavirus Vaccine Market.
- To identify key sustainable strategies adopted by market players in the Global Coronavirus Vaccine Market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers which could not be identified due to the limitations of secondary research. The publisher analyzed the manufacturers, distribution channels and presence of all major players across the globe.
The publisher calculated the market size of the Global Coronavirus Vaccine Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.
Key Target Audience:
- Coronavirus vaccine manufacturers, suppliers, distributors, and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to coronavirus vaccine
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.
Report Scope:
In this report, the Global Coronavirus Vaccine Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Global Coronavirus Vaccine Market, By Infection Type:
- SARS-CoV-2
- SARS-CoV
- MERS-CoV
Global Coronavirus Vaccine Market, By Vaccine Type:
- Virus Vaccine
- Viral Vector Vaccine
- Nucleic Acid Vaccine
- Protein Based Vaccine
- Others
Global Coronavirus Vaccine Market, By Product Type:
- Monovalent Vaccine
- Multivariant Vaccine
Global Coronavirus Vaccine Market, By Route of Administration:
- Intramuscular
- Oral
- Intranasal
Global Coronavirus Vaccine Market, By Patient Type:
- Adult
- Pediatric
Global Coronavirus Vaccine Market, By End-User:
- Hospitals
- Clinics
- Research Institutes
- Others
Global Coronavirus Vaccine Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Asia-Pacific
- China
- India
- Singapore
- Japan
- South Korea
- Hong Kong
- Australia
- Thailand
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- UAE
- Saudi Arabia
- Kuwait
- South Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Coronavirus Vaccine Market.
Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.
Table of Contents
1. Product Overview2. Research Methodology
3. Impact of COVID-19 on Global Coronavirus Vaccine Market
4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness
5.2. Vaccine Efficacy
5.3. Patient Satisfaction Analysis
5.4. Post-Vaccination Side Effects
6. Global Coronavirus Vaccine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value and By Volume
6.2. Market Share & Forecast
6.2.1. By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV)
6.2.2. By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based Vaccine, Others)
6.2.3. By Product Type (Monovalent Vaccine v/s Multivariant Vaccine)
6.2.4. By Route of Administration (Intramuscular, Oral, Intranasal)
6.2.5. By Patient Type (Adult v/s Pediatric)
6.2.6. By End User (Hospitals, Clinics, Research Institutes, Others)
6.2.7. By Company (2020)
6.2.8. By Region
6.3. Market Map
7. North America Coronavirus Vaccine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Infection Type
7.2.2. By Vaccine Type
7.2.3. By Product Type
7.2.4. By Route of Administration
7.2.5. By Patient Type
7.2.6. By End User
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Coronavirus Vaccine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Infection Type
7.3.1.2.2. By Vaccine Type
7.3.1.2.3. By Product Type
7.3.1.2.4. By Route of Administration
7.3.1.2.5. By Patient Type
7.3.1.2.6. By End User
7.3.2. Mexico Coronavirus Vaccine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Infection Type
7.3.2.2.2. By Vaccine Type
7.3.2.2.3. By Product Type
7.3.2.2.4. By Route of Administration
7.3.2.2.5. By Patient Type
7.3.2.2.6. By End User
7.3.3. Canada Coronavirus Vaccine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Infection Type
7.3.3.2.2. By Vaccine Type
7.3.3.2.3. By Product Type
7.3.3.2.4. By Route of Administration
7.3.3.2.5. By Patient Type
7.3.3.2.6. By End User
8. Europe Coronavirus Vaccine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Infection Type
8.2.2. By Vaccine Type
8.2.3. By Product Type
8.2.4. By Route of Administration
8.2.5. By Patient Type
8.2.6. By End User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. United Kingdom Coronavirus Vaccine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Infection Type
8.3.1.2.2. By Vaccine Type
8.3.1.2.3. By Product Type
8.3.1.2.4. By Route of Administration
8.3.1.2.5. By Patient Type
8.3.1.2.6. By End User
8.3.2. Germany Coronavirus Vaccine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Infection Type
8.3.2.2.2. By Vaccine Type
8.3.2.2.3. By Product Type
8.3.2.2.4. By Route of Administration
8.3.2.2.5. By Patient Type
8.3.2.2.6. By End User
8.3.3. France Coronavirus Vaccine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Infection Type
8.3.3.2.2. By Vaccine Type
8.3.3.2.3. By Product Type
8.3.3.2.4. By Route of Administration
8.3.3.2.5. By Patient Type
8.3.3.2.6. By End User
8.3.4. Italy Coronavirus Vaccine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Infection Type
8.3.4.2.2. By Vaccine Type
8.3.4.2.3. By Product Type
8.3.4.2.4. By Route of Administration
8.3.4.2.5. By Patient Type
8.3.4.2.6. By End User
8.3.5. Spain Coronavirus Vaccine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Infection Type
8.3.5.2.2. By Vaccine Type
8.3.5.2.3. By Product Type
8.3.5.2.4. By Route of Administration
8.3.5.2.5. By Patient Type
8.3.5.2.6. By End User
9. Asia-Pacific Coronavirus Vaccine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Infection Type
9.2.2. By Vaccine Type
9.2.3. By Product Type
9.2.4. By Route of Administration
9.2.5. By Patient Type
9.2.6. By End User
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Coronavirus Vaccine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Infection Type
9.3.1.2.2. By Vaccine Type
9.3.1.2.3. By Product Type
9.3.1.2.4. By Route of Administration
9.3.1.2.5. By Patient Type
9.3.1.2.6. By End User
9.3.2. India Coronavirus Vaccine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Infection Type
9.3.2.2.2. By Vaccine Type
9.3.2.2.3. By Product Type
9.3.2.2.4. By Route of Administration
9.3.2.2.5. By Patient Type
9.3.2.2.6. By End User
9.3.3. Singapore Coronavirus Vaccine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Infection Type
9.3.3.2.2. By Vaccine Type
9.3.3.2.3. By Product Type
9.3.3.2.4. By Route of Administration
9.3.3.2.5. By Patient Type
9.3.3.2.6. By End User
9.3.4. Japan Coronavirus Vaccine Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Infection Type
9.3.4.2.2. By Vaccine Type
9.3.4.2.3. By Product Type
9.3.4.2.4. By Route of Administration
9.3.4.2.5. By Patient Type
9.3.4.2.6. By End User
9.3.5. South Korea Coronavirus Vaccine Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Infection Type
9.3.5.2.2. By Vaccine Type
9.3.5.2.3. By Product Type
9.3.5.2.4. By Route of Administration
9.3.5.2.5. By Patient Type
9.3.5.2.6. By End User
9.3.6. Hong Kong Coronavirus Vaccine Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Infection Type
9.3.6.2.2. By Vaccine Type
9.3.6.2.3. By Product Type
9.3.6.2.4. By Route of Administration
9.3.6.2.5. By Patient Type
9.3.6.2.6. By End User
9.3.7. Australia Coronavirus Vaccine Market Outlook
9.3.7.1. Market Size & Forecast
9.3.7.1.1. By Value
9.3.7.2. Market Share & Forecast
9.3.7.2.1. By Infection Type
9.3.7.2.2. By Vaccine Type
9.3.7.2.3. By Product Type
9.3.7.2.4. By Route of Administration
9.3.7.2.5. By Patient Type
9.3.7.2.6. By End User
9.3.8. Thailand Coronavirus Vaccine Market Outlook
9.3.8.1. Market Size & Forecast
9.3.8.1.1. By Value
9.3.8.2. Market Share & Forecast
9.3.8.2.1. By Infection Type
9.3.8.2.2. By Vaccine Type
9.3.8.2.3. By Product Type
9.3.8.2.4. By Route of Administration
9.3.8.2.5. By Patient Type
9.3.8.2.6. By End User
10. South America Coronavirus Vaccine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Infection Type
10.2.2. By Vaccine Type
10.2.3. By Product Type
10.2.4. By Route of Administration
10.2.5. By Patient Type
10.2.6. By End User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Coronavirus Vaccine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Infection Type
10.3.1.2.2. By Vaccine Type
10.3.1.2.3. By Product Type
10.3.1.2.4. By Route of Administration
10.3.1.2.5. By Patient Type
10.3.1.2.6. By End User
10.3.2. Argentina Coronavirus Vaccine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Infection Type
10.3.2.2.2. By Vaccine Type
10.3.2.2.3. By Product Type
10.3.2.2.4. By Route of Administration
10.3.2.2.5. By Patient Type
10.3.2.2.6. By End User
10.3.3. Colombia Coronavirus Vaccine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Infection Type
10.3.3.2.2. By Vaccine Type
10.3.3.2.3. By Product Type
10.3.3.2.4. By Route of Administration
10.3.3.2.5. By Patient Type
10.3.3.2.6. By End User
11. Middle East and Africa Coronavirus Vaccine Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Infection Type
11.2.2. By Vaccine Type
11.2.3. By Product Type
11.2.4. By Route of Administration
11.2.5. By Patient Type
11.2.6. By End User
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. UAE Coronavirus Vaccine Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Infection Type
11.3.1.2.2. By Vaccine Type
11.3.1.2.3. By Product Type
11.3.1.2.4. By Route of Administration
11.3.1.2.5. By Patient Type
11.3.1.2.6. By End User
11.3.2. Saudi Arabia Coronavirus Vaccine Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Infection Type
11.3.2.2.2. By Vaccine Type
11.3.2.2.3. By Product Type
11.3.2.2.4. By Route of Administration
11.3.2.2.5. By Patient Type
11.3.2.2.6. By End User
11.3.3. Kuwait Coronavirus Vaccine Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Infection Type
11.3.3.2.2. By Vaccine Type
11.3.3.2.3. By Product Type
11.3.3.2.4. By Route of Administration
11.3.3.2.5. By Patient Type
11.3.3.2.6. By End User
11.3.4. South Africa Coronavirus Vaccine Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Infection Type
11.3.4.2.2. By Vaccine Type
11.3.4.2.3. By Product Type
11.3.4.2.4. By Route of Administration
11.3.4.2.5. By Patient Type
11.3.4.2.6. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Moderna, Inc.
14.2.2. Pfizer Inc.
14.2.3. Johnson & Johnson SA
14.2.4. Sinopharm Group Company Ltd.
14.2.5. AstraZeneca PLC
14.2.6. Serum Institute of India Pvt Ltd.
14.2.7. Bharat Biotech International Ltd.
14.2.8. Sinovac Biotech Ltd.
14.2.9. Sanofi SA
14.2.10. GlaxoSmithKline PLC
14.2.11. Novavax, Inc.
14.2.12. Airway Therapeutics, Inc.
14.2.13. Cadila Healthcare Ltd.
14.2.14. CanSino Biologics Inc.
14.2.15. Mitsubishi Chemical Holdings Corporation
14.2.16. Eubiologics Co. Ltd.
14.2.17. United Biomedical Inc.
14.2.18. Merck & Co., Inc.
14.2.19. CureVac N.V.
14.2.20. Inovio Pharmaceuticals, Inc.
15. Strategic Recommendations
16. About the Publisher & DisclaimerList of Figures
Figure 1: Global Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
Figure 2: Global Coronavirus Vaccine Market Share, By Volume (Million Units), 2020-2026F
Figure 3: Global Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 4: Global Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 5: Global Coronavirus Vaccine Market Share, By Product Type, By Value 2020-2026F
Figure 6: Global Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 7: Global Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 8: Global Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 9: Global Coronavirus Vaccine Market Share, Market Map, By Region, By Value, 2020-2026F
Figure 10: North America Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
Figure 11: North America Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 12: North America Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 13: North America Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 14: North America Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 15: North America Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 16: North America Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 17: North America Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
Figure 18: United States Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 19: United States Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 20: United States Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 21: United States Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 22: United States Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 23: United States Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 24: Mexico Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 25: Mexico Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 26: Mexico Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 27: Mexico Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 28: Mexico Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 29: Mexico Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 30: Canada Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 31: Canada Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 32: Canada Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 33: Canada Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 34: Canada Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 35: Canada Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 36: Europe Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
Figure 37: Europe Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 38: Europe Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 39: Europe Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 40: Europe Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 41: Europe Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 42: Europe Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 43: Europe Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
Figure 44: United Kingdom Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 45: United Kingdom Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 46: United Kingdom Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 47: United Kingdom Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 48: United Kingdom Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 49: United Kingdom Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 50: Germany Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 51: Germany Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 52: Germany Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 53: Germany Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 54: Germany Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 55: Germany Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 56: France Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 57: France Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 58: France Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 59: France Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 60: France Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 61: France Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 62: Italy Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 63: Italy Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 64: Italy Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 65: Italy Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 66: Italy Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 67: Italy Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 68: Spain Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 69: Spain Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 70: Spain Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 71: Spain Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 72: Spain Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 73: Spain Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 74: APAC Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
Figure 75: APAC Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 76: APAC Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 77: APAC Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 78: APAC Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 79: APAC Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 80: APAC Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 81: APAC Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
Figure 82: China Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 83: China Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 84: China Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 85: China Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 86: China Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 87: China Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 88: India Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 89: India Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 90: India Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 91: India Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 92: India Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 93: India Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 94: Singapore Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 95: Singapore Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 96: Singapore Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 97: Singapore Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 98: Singapore Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 99: Singapore Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 100: Japan Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 101: Japan Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 102: Japan Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 103: Japan Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 104: Japan Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 105: Japan Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 106: South Korea Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 107: South Korea Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 108: South Korea Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 109: South Korea Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 110: South Korea Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 111: South Korea Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 112: Hong Kong Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 113: Hong Kong Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 114: Hong Kong Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 115: Hong Kong Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 116: Hong Kong Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 117: Hong Kong Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 118: Australia Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 119: Australia Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 120: Australia Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 121: Australia Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 122: Australia Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 123: Australia Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 124: Thailand Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 125: Thailand Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 126: Thailand Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 127: Thailand Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 128: Thailand Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 129: Thailand Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 130: South America Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
Figure 131: South America Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 132: South America Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 133: South America Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 134: South America Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 135: South America Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 136: South America Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 137: South America Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
Figure 138: Brazil Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 139: Brazil Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 140: Brazil Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 141: Brazil Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 142: Brazil Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 143: Brazil Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 144: Argentina Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 145: Argentina Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 146: Argentina Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 147: Argentina Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 148: Argentina Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 149: Argentina Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 150: Colombia Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 151: Colombia Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 152: Colombia Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 153: Colombia Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 154: Colombia Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 155: Colombia Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 156: MEA Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
Figure 157: MEA Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 158: MEA Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 159: MEA Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 160: MEA Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 161: MEA Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 162: MEA Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 163: MEA Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
Figure 164: UAE Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 165: UAE Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 166: UAE Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 167: UAE Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 168: UAE Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 169: UAE Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 170: Saudi Arabia Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 171: Saudi Arabia Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 172: Saudi Arabia Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 173: Saudi Arabia Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 174: Saudi Arabia Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 175: Saudi Arabia Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 176: Kuwait Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 177: Kuwait Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 178: Kuwait Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 179: Kuwait Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 180: Kuwait Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 181: Kuwait Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 182: South Africa Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 183: South Africa Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 184: South Africa Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 185: South Africa Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 186: South Africa Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 187: South Africa Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Moderna, Inc
- Pfizer Inc
- Johnson & Johnson SA
- Sinopharm Group Company Ltd
- AstraZeneca PLC
- Serum Institute of India Pvt Ltd
- Bharat Biotech International Ltd
- Sinovac Biotech Ltd
- Sanofi SA
- GlaxoSmithKline PLC
- Novavax, Inc
- Airway Therapeutics, Inc
- Cadila Healthcare Ltd
- CanSino Biologics Inc
- Mitsubishi Chemical Holdings Corporation
- Eubiologics Co Ltd
- United Biomedical Inc
- Merck & Co, Inc
- CureVac NV
- Inovio Pharmaceuticals, Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 119 |
| Published | July 2021 |
| Forecast Period | 2020 - 2026 |
| Estimated Market Value ( USD | $ 15241.23 Million |
| Forecasted Market Value ( USD | $ 23562.25 Million |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
